Loading organizations...
Loading organizations...
Global clinical-stage biopharmaceutical company focused on oncology drugs.
Adlai Nortye has raised $153.0M across 2 funding rounds.
Adlai Nortye has raised $153.0M in total across 2 funding rounds.
Adlai Nortye has raised $153.0M in total across 2 funding rounds.
Adlai Nortye's investors include Matrix Partners China, Yahui Investment, YuanMing Capital.
Adlai Nortye has raised $153.0M across 2 funding rounds. Most recently, it raised $100.0M Series C in August 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 31, 2020 | $100.0M Series C | ||
| Jul 5, 2018 | $53.0M Series B | Matrix Partners China, Yahui Investment, YuanMing Capital |